There is no penalty for going slow
Theyre also testing newer and more powerful meds
This outcome is thought to be an effect of all medications that increase GLP-1, because of both an increase in SDF-1-alpha and capillary density due to increased hypoxia-inducible factor 1-alpha and vascular endothelial growth factor
Getting the right fit helps you avoid unnecessary struggle and sets you up for long-term success
The mechanism is additive, not duplicative
June 23, 2026Download PDF Story at-a-glance GLP-1 drugs such as Ozempic and Wegovy have been linked to serious vision concerns, including diabetic retinopathy and optic nerve damage that can result in lasting vision loss Research suggests the highest risk of sudden vision loss may occur within the first year of starting these drugs, with symptoms sometimes appearing overnight without pain or warning Case reports document that even healthy adults using GLP-1 drugs for weight loss with no history of diabetes or eye disease have experienced lasting vision loss Sudden changes in vision such as blurriness, blind spots, or loss of color perception may be early warning signs of optic nerve damage